Correlation Between Fubon MSCI and SCI Pharmtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and SCI Pharmtech, you can compare the effects of market volatilities on Fubon MSCI and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and SCI Pharmtech.

Diversification Opportunities for Fubon MSCI and SCI Pharmtech

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fubon and SCI is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Fubon MSCI and SCI Pharmtech

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 1.33 times more return on investment than SCI Pharmtech. However, Fubon MSCI is 1.33 times more volatile than SCI Pharmtech. It trades about 0.03 of its potential returns per unit of risk. SCI Pharmtech is currently generating about -0.31 per unit of risk. If you would invest  14,430  in Fubon MSCI Taiwan on October 22, 2024 and sell it today you would earn a total of  95.00  from holding Fubon MSCI Taiwan or generate 0.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Fubon MSCI Taiwan  vs.  SCI Pharmtech

 Performance 
       Timeline  
Fubon MSCI Taiwan 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Fubon MSCI is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
SCI Pharmtech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCI Pharmtech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SCI Pharmtech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Fubon MSCI and SCI Pharmtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fubon MSCI and SCI Pharmtech

The main advantage of trading using opposite Fubon MSCI and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.
The idea behind Fubon MSCI Taiwan and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios